Home Search Contacts Help
ABPI - The Association of the British Pharmaceutical Industry
 
Target Alzheimer's

 

Alzheimer's - Some Questions and Answers

What is Alzheimer's?

Alzheimer's is the commonest of a group of illnesses called dementias which affect the human brain. First described by Alois Alzheimer in 1907, it is a progressive disorder in which there is a slow but relentless destruction of nerve cells. This destruction does not occur uniformly, but affects certain areas such as the hippocampus and amygdala buried deep inside the brain, and parts of the outer (cortical) areas, thus leading to selective loss of mental function, especially memory.

back to top

What is dementia?

Dementia is a medical term used to describe a general decline in mental ability. The Royal College of Physicians' definition reads as follows:

Dementia is the global impairment of higher cortical functions, including memory, the capacity to solve the problems of day-to-day living, the performance of learned perceptuo-motor skills, the correct use of social skills and control of emotional reactions, in the absence of gross clouding of consciousness. The condition is often irreversible and progressive.

Within this definition, you can find all the major characteristics of Alzheimer's - memory loss, problems in daily living, difficulty in carrying out simple practical tasks, inappropriate responses to situations requiring social awareness or emotional control, and its progressive nature.

back to top

Are there other types of dementia?

There are several other forms of dementia. The commonest after Alzheimer's are vascular dementia and Lewy body dementia. The former is caused by numerous blockages in blood flow to small areas of the brain caused, for example, by very minor strokes. Over a period of time, the cumulative brain damage begins to manifest itself as vascular dementia. Lewy body dementia has some similarities with Alzheimer's, but on closer examination, some of the symptoms are seen to be different and the structures inside neurons, called Lewy bodies, that are visible after death are clearly different. These types will not be discussed further in this booklet, but specific leaflets on them are available from the Alzheimer's Society.

back to top

Can a doctor distinguish between Alzheimer's and other forms of dementia?

There is no simple clinical test to separate Alzheimer's from other forms of dementia, so the doctor will have to rely heavily on the pattern of onset of the symptoms and the medical history of the person concerned. First, he will need to rule out other possible causes of the symptoms such as vitamin or thyroid hormone deficiencies, depression, or the side effects of some medicines or their combinations. Then he will consider the family history, and finally, seek an assessment by someone skilled to apply and interpret simple tests of mental performance. Taken together, the results will enable a correct diagnosis to be made in 9 cases out of 10. An absolute diagnosis, however, can only be made after death, when structures called amyloid (senile) plaques and neurofibrillary tangles made of an abnormal protein called tau can be demonstrated in the brain.

back to top

Who is affected by Alzheimer's?

All forms of dementia rise steeply with age. In the case of Alzheimer's, fewer than one person in 1,000 under the age of 65 is affected, rising to about 3 per cent between the ages of 65 and 74, and from 10 to 15 per cent in the over 85s. Despite these figures, most people over the age of 80 remain mentally alert, so age itself does not inevitably lead to this condition. Alzheimer's affects both men and women from all races, cultures and social backgrounds. It appears to be more common in women, but this is at least partly due to the fact that they have a life expectancy significantly longer than men.

The small number who develop Alzheimer's early (between the ages of 35 and 60) usually have a family history of the disorder, and recent studies suggest that such individuals carry genes that place them at greater risk.

back to top

How common is Alzheimer's?

Alzheimer's has become much more common in the past 40 to 50 years, because Britain now has a rapidly ageing population and thus many more vulnerable people. About 700,000 people in the UK have dementia, and of those, just over 55 per cent have Alzheimer's. People with Alzheimer's in the USA number about 4 million, while world-wide, the estimated total is 12 million. Unless successful treatments can be found, this global figure is expected to rise to around 22 million by 2025, because the over-65 population will double from 390 to 800 million in that time.

back to top

What are the main symptoms of Alzheimer's?

At the outset, symptoms are variable and innocuous, and easily mistaken for normal ageing. Common early signs are memory loss (especially for recent events), confusion, poor concentration, disorientation, and sometimes changes in personality. These signs worsen at varying rates between individuals and in later stages may be accompanied by aggressive behaviour, depression or a tendency to wander off. Symptoms continue to worsen with, eventually, almost complete loss of memory, failure to recognise surroundings and loved ones, loss of language, and of the ability to recognise and use familiar objects. By now, judgement and the ability to engage in any kind of intellectual pursuits will have vanished and the individual becomes fully dependent for all their basic needs. Finally, people with Alzheimer's often become wasted and eventually die of infections or other physical causes.

back to top

Can Alzheimer's be cured?

There is no cure for Alzheimer's and this is unlikely once significant loss of nerve cells has taken place. However, a medicine that prevented further deterioration while the person was still able to interact meaningfully with their surroundings and family would be a great advance. That goal at least might be achievable. Although some years away, a vaccine that would stop the onset of the illness seems a possibility. If safe, it could be given to people at risk or even to everyone once they reach their most vulnerable age.

back to top

Can Alzheimer's be prevented or slowed down?

The areas of the brain most affected by Alzheimer's are rich in a chemical messenger called acetylcholine (ACh). This is produced in the brain by an enzyme called choline acetyltransferase (ChAT) and broken down by another enzyme called acetylcholine esterase (AChE).

The levels of ChAT fall in the brain of a person with Alzheimer's, so less ACh is made, and yet its rapid breakdown continues. Three medicines are now available on the UK market which help maintain the level of acetylcholine. Evidence suggests that they benefit mental acuity and awareness, and can help some people with mild memory loss for up to a year and possibly longer. Eventually though, the benefit wears off and the downward progression resumes. As our understanding improves, better medicines of this type might have longer-lasting effects.

back to top

Are there any known risk factors for Alzheimer's?

A risk factor is anything that might increase someone's chance of developing a particular condition. In the case of Alzheimer's, the major risk factor is clearly age, but that is one we can do little about. Women are also slightly more vulnerable, possibly due to lowered oestrogen levels after the menopause. Head injury, especially if it is accompanied by unconsciousness, certain viral infections such as cold sores (though the precise relationship is complex and still unproven), some dietary factors, and a poor level of education have also been implicated, but the evidence is far from proven. Culture may also be involved. For example, studies in China suggest that rates there are lower, and others comparing people over 65 of African origin living in either the USA or Nigeria found fewer cases in those living in Africa. Cigarette smoking may be slightly protective, possibly due to the stimulation of N receptors by nicotine.

back to top

Is Alzheimer's inherited?

It is known that Alzheimer's sometimes clusters in families and this suggests that genetic make-up can play a part. But this is not always so and many cases - called 'sporadic'- occur when there is no family history. Studies of this aspect of Alzheimer's have accelerated in recent years as a result of the revolution in molecular biology. Through such techniques, it has been shown that in about 5 per cent of people, Alzheimer's is caused by a mutation in one of three genes. These people almost invariably develop what is called ‘early-onset Alzheimer's', where symptoms sometimes begin as early as age 30 and nearly always before the age of 65.

The first gene to be linked to early onset Alzheimer's is called APP (Amyloid Precursor Protein). Mutations in APP are very rare indeed, so the search went on for other genes. In 1995, a second was found, called the Presenilin-1 (PS1) gene. Mutations in this account for between 50 and 60 per cent of cases. Soon after this, another gene called Presenilin-2 (PS2) was discovered, accounting for another 10 per cent. Genes responsible for the remaining cases are still being tracked down.

In the case of the majority - the 95 per cent of people who get late-onset Alzheimer's - some genes have been identified that are thought to increase the relative risk but do not cause Alzheimer's directly. The most studied is called the APOE (apolipoprotein E) gene, which exists in several forms in different people. One in particular, called 4, has been shown in over 50 studies to have a relationship with Alzheimer's. People unlucky enough to have a pair of 4 genes (one on each of the pair of chromosome 19) will usually develop Alzheimer's before the age of 70, while those with either 2 + 4 or 3 + 4 will on average not show symptoms until they are over 90, i.e. the possession of 2 or 3 can actually protect against the risk associated with having 4. In any case, the possession of the 4 gene only accounts for about 50 per cent of cases of the late-onset type, so other genes are also likely to be involved. Several are under active investigation. By understanding what processes these genes orchestrate in the brain, it has been possible to devise new approaches to medicines discovery.

back to top

Jennie's diary conveys her growing sense of insecurity, fear, confusion and distrust. At the time these entries begin, she was a kindly lady just diagnosed with Alzheimer's, but cared for and visited at least three times a week by her daughter and friends. The words, spelling, punctuation and underlining are hers.
Jan. 23rd 1997 Now Saturday must remember to write my diary every night. Diana [daughter] came sometime but I can't remember when. My memory is bad. I don't remember things. It is very difficult on your own.
Feb. 4th Damp dull morning usual things. Just been giving myself a good talking to about not writing my diary every evening. I think my memory is getting very bad its worrying. I think I spent the morning looking for something, I think my purse. Very windy.
Mar. 15th Went to village for pension. Afternoon sorting out pension. missing £10 out of my purse.
May 13th Diana came this morning can't remember what for. didn't stay for dinner. Rang Diana and she came to tell me Bert [brother] died. How could I forget that. I am now realising I am doing silly things.
June 26th I am tired bit achy today. Keep forgetting. Must remember to ask Diana to write things down then I know what is going on, otherwise they think you know and you look a fool, and they think you are scatty.
July 17th Talk to Jan [friend] went for pension pay papers. Lost £10 note taken from my purse.
July 22nd Lovely day usual things. it is now evening just walked along to park. I am worried about loosing money. I have no one to talk to about it. I'm wondering about asking the solicitor to come.
Aug. 17th Money taken out of bank. That is very worrying. I feel sad about it when no one tells you and you just find out. I don't like Sundays. Bad pain in my hip I think I'm living too long.
Aug. 27th Rang Diana and talked to Mike [son-in-law]. He says I rang yesterday. Forgot I rang yesterday must write these things down. it's because I am on my own so no one reminds me.
Aug. 31st Showery usual things. It's been an odd sort of day. Now 4pm won't go out. Don't know why its such an odd sort of day. Wish Ivor [deceased husband] was still with me. Princess Diana and Dodi killed in car crash.
Sept. 28th Just found out I haven't written my diary since 21st. Good job I get paper or I wouldn't know the day, date or year. Afternoon I was looking for some things don't know what. Found so many picture snaps the afternoon has gone. Jean [neighbour] brought salmon sandwiches and cake. Very nice.
Dec. 6th Rang Diana. She seemed mad with me. don't know why. New pills must swallow whole.
Dec. 21st Dull misty morning. Envelopes all over the place some full some empty. Can't cope any more. It makes me cry but that won't help. I forgot to go to church and I wanted to go this morning.
Jan. 4th 1998 Don't like the feeling just recently. I feel I don't know what's going on. I think I ought to move to Arnside. Must get my money sorted out something odd is going on. If anything is different I get very confused, I am living too long.
Jan. 23rd Rang Mike this morning to tell him not to let me do silly things. I think the fairies have been back in my bathroom. I seem to be getting everything wrong.
Mar. 6th Paper says its Friday I thought it was Tuesday. Diana and Mike may be away but can't remember. If people ask me I'll feel a fool. Now 9th - not in America - keep my mouth shut or I'll be in trouble.
May 9th I feel a nuisance to Diana. I have been looking for something. I have been looking so long I can't remember what I am looking for. I am very miserable and frightened. I would like to move, there is only me in this road.
May 23rd Dull. Usual things. Trying to sort myself out. If only I had my Dad's shaving tin back. I will never forget it being taken from me. I am very unhappy and upset. Only £40 today and only Saturday. Thursday I got £66.63. Someone is taking my things.
June 17th Went to Pine Lodge home [a retirement home] while Diana and Mike are away.
July 7th Don't know why I'm at Pine Lodge. I'm fed up. No friends. I'm fed up with people trying to run my life.
July 11th I think I must have come home from Pine Lodge today. Home from Pine Lodge. I feel very odd and unhappy and don't really know where I am. I'm frightened.
July 19th I don't know anything and all my pencils seem to have disappeared. Someone has taken my comb. I don't know why but I think it is rotten. Going back to Pine Lodge.
Aug. 7th I don't like Pine Lodge. These places can send you round the bend. I am very frightened this morning. Things are going on in my house and I am terrified. People in my house at night. I am frightened and don't know how to sort it out. I'm frightened to go out of my bedroom.
Sept. 7th Just found out I am in Pine Lodge for ever. Lived too long. Diana is rotten. Now 5am. Terrified. Don't know where I am or where I belong. I am frightened and not in Pine Lodge.
Feb. 8th 1999 I am in a mess. Life isn't nice when you are alone. Diana will you please come and help me. I have forgotten to tell you things.
Entries became very sporadic after October 1998. February 8th 1999 was the last coherent entry, a real cry from the heart. Today, Jennie is still at Pine Lodge but losing recognition of friends and family. Memories are now mostly of childhood places and events, but she is no longer frightened.
back to top

How do we know these genes are related to Alzheimer's?

One way is to carry out population studies to determine which genes and mutations are present in small tissue samples from people with and without Alzheimer's. In this way, specific gene defects can be linked to the illness.

Perhaps the most persuasive evidence comes from studies of special strains of mice in which mutations are present. It has been shown that mice with the APP mutation have trouble learning and remembering as they get older, and both the APP and PS-1 gene cause the development of amyloid plaques in mice, just like those in humans, though not neurofibrillary tangles.

back to top

Can diet influence the development of Alzheimer's?

Some reports suggested that a high intake of aluminium can act as a trigger for Alzheimer's. However, it has proved impossible to confirm this link and current opinion is that aluminium has little, if any, involvement.

The role of several vitamins has also been investigated. The University of Oxford Optima Study looked at the ageing brain over many years by analysing scans and blood samples. Among their findings were that people with lower blood levels of vitamin B12 or folic acid (another member of the B vitamin group) were four times and three times as likely to develop Alzheimer's respectively compared to people with normal levels. Vitamin E has also been studied and one large trial reported that vitamin E slowed the progression of moderate to severe Alzheimer's and the time before nursing home care became necessary.

Recent data suggests that 40-59 year-old people with the 4 gene who have 40 per cent or more fat in their diet in mid-life have a 29-fold higher risk of developing Alzheimer's compared to non-4 carriers. A second group with 35 per cent or less fat in their diet only had a 4-fold risk increase.

A frequent problem in people with Alzheimer's is loss of body weight, probably caused by inappropriate diet or neglect of eating. Such weight loss in Alzheimer's correlates with the loss of brain tissue and possibly with acceleration of the dementia process. So it is important to ensure that people with early signs of dementia have an environment where they are encouraged to eat and that they have a good, balanced diet. This is explored in much more detail in Food for Thought, a booklet available from the Alzheimer's Society.

back to top

What are the main types of medicines used to treat Alzheimer's?

Many medicines are used in Alzheimer's, but not to treat it. They can only relieve symptoms such as anxiety, depression, agitation and aggression. Their effects can often be beneficial, but they do not address the underlying disorder and will not be considered further here.

Three medicines specifically developed for Alzheimer's are available in the UK for treating mild to moderate illness and all have been approved for prescription on the NHS. They are:

  • donepezil (Eisai/Pfizer)
  • rivastigmine (Novartis) and
  • galantamine (Shire/Janssen)

All three belong to a class of compounds that prevent the breakdown of the brain chemical, ACh, mentioned previously. They can stabilise or improve some of the early symptoms in mild to moderate Alzheimer's.

back to top

What impact does Alzheimer's have on the family?

If someone that you love and care for develops dementia, the impact can be quite devastating. Alzheimer's develops differently in different people and may involve memory problems - at first slight, but later very severe behavioural changes such as aggression and mood swings, irrational actions such as going out for a walk at night dressed in night clothes, and the breakdown of normal reasoning processes that can lead to distrust, suspicion, unfounded accusations, and quite inappropriate behaviour. In the later stages, a high degree of physical dependence may also develop, so that simple everyday activities like dressing, going to the toilet and eating become almost impossible without help. In the final stages, these problems may pose such difficulties that care at home is no longer possible.

These changes often cause enormous distress for carers and can lead to profound feelings of guilt. They may impose great strains on family life and marriages, require the involvement of many outside agencies which can disrupt the usual patterns of behaviour and social life, cause financial worries, and impose a huge psychological impact as the loved one slowly but surely slips away into an impenetrable twilight world. Perhaps most frustrating of all is the knowledge that there is so little that can be done to stop the process.

These important issues cannot be addressed in this short booklet, but a helping hand will always be there from the Alzheimer's Society and its local support groups.

back to top

What kind of information and support is available for people with Alzheimer's?

Confirmation that you or a close relative has Alzheimer's is likely to be a traumatic and frightening experience. Many people in this position will experience a period of shock while the news sinks in, after which they are likely to begin an appraisal of the impact of the news. These reactions are natural, but it is important that clear explanations are given at this time, that appropriate support is available, and that there is some way of getting answers to the many questions that will arise. In particular with a condition like Alzheimer's, there is a need to be informed of the wide range of services available and how they can best be co-ordinated for each individual.

Social Services are able to carry out an assessment to determine the needs of the individual and can advise on the statutory entitlements that are available. There will also be a host of everyday problems as the disorder worsens. Some of these may be addressed by occupational, speech and language therapists, community psychiatric nurses, health visitors, physiotherapists and chiropodists. Some answers to the many questions that arise can be provided by these people or by the GP or specialist, but they may not always be available when needed. The Alzheimer's Society offers a comprehensive support service, including a telephone helpline, as well as an extensive and well written series of booklets and information sheets dealing with almost every aspect of Alzheimer's that you are likely to meet. There are also several useful books such as:

  • Alzheimer's at Your Fingertips, by Cayton, Graham and Warner, published by Class Publishing, London [ISBN 1-872362-71-0].
  • Opening the Mind: New Frontiers in Alzheimer's Research, published by the Alzheimer's Society
  • Caring for a Person with Dementia: a Guide for Families and Other Carers, published by the Alzheimer's Society

The Alzheimer's Society also has an extensive range of leaflets dealing with subjects as diverse as the various forms of dementia to social services, Council Tax implications and welfare benefits. There is also a network of local support groups throughout the British Isles.

back to top

 

 

 

 

 

 

 

 

 

 

 

 

 

Brain areas in the cortex where nerve cells are damaged and dying. The darker the shade of blue, the greater the damage. Many of the areas most affected are memory centres.

Click here for larger image

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The commonest types of dementia and their percentage frequency in the population

Click here for larger image

 

 

Amyloid plaques (larger bodies) and neurofibrillary tangles (smaller dots) in the brain of an Alzheimer’s patient

Click here for larger image

 

 

The frequency with which dementia occurs in the population in different age groups

Click here for larger image

 

 

Britain's aging population. Note the large increase in the 75-84 and the over 85 age groups anticipated by the year 2041

Click here for larger image

 

 

 

Possible risk factors for Alzheimer’s disease

Click here for larger image

 

 

 

 

 

 


A few families are genetically
susceptible to early onset
Alzheimer’s. In this family
tree, 14 out of 29 developed
the illness over four generations

Click here for larger image

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Relative frequency of early and late-onset Alzheimer’s
and the proportion of early-onset cases attributed to
mutations in specific genes
such as APP, PS1, PS2 or
others

Click here for larger image

 
Previous Page | Print Page | Top of Page
Copyright © ABPI - The Association of the British Pharmaceutical Industry Terms and Conditions | Privacy Policy